Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongke Meiling Cryogenics, operating under the brand Meling Biomedical, is a leading provider of low-temperature storage and cold chain solutions for the life sciences and healthcare sectors. Founded as a joint venture between Changhong Meling and the Chinese Academy of Sciences, the company specializes in the research, development, and manufacturing of ultra-low temperature freezers, medical refrigerators, and automated biobanking systems. Its products are essential for preserving biological specimens, vaccines, and pharmaceuticals in research institutions, blood banks, and hospitals worldwide. The company has transitioned from a terminal equipment manufacturer to a comprehensive service provider, offering intelligent monitoring and digital biobank management solutions. Zhongke Meiling is publicly traded on the Beijing Stock Exchange and maintains a significant global presence across more than 50 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cryogenics.